Navan is rated a "Sell" as AI-driven headcount cuts may hit corporate travel volumes, revenue, and margins. Here's what you ...
Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
The AUD/USD pair is down 0.23% to near 0.7065 in the late Asian trading session, struggling to extend its winning streak for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results